Immune biomarkers in thymic epithelial tumors: expression patterns, prognostic value and comparison of diagnostic tests for PD-L1

• Main Authors: Isabelle Rouquette (Author), Estelle Taranchon-Clermont (Author), Julia Gilhodes (Author), Maria-Virginia Bluthgen (Author), Romain Perallon (Author), Lara Chalabreysse (Author), Anne De Muret (Author), Veronique Hofman (Author), Alexander Marx (Author), Marie Parrens (Author), Veronique Secq (Author), Vincent Thomas de Montpreville (Author), Françoise Galateau-Salle (Author), Pierre Brousset (Author), Julie Milia (Author), Nicolas Girard (Author), Benjamin Besse (Author), Thierry Jo Molina (Author), Julien Mazières (Author)
• Format: Book
• Published: BMC, 2019-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Immunotherapy is currently under investigation in B3 Thymoma (TB3) and Thymic Carcinoma (TC). PD-L1 expression has been evaluated on a limited number of patients with selected antibodies. We aimed to analyze cohort of TB3 and TC with a panel of antibodies to assess the prevalence...